CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Grant or award Director acquired 7,609 shares (grant or award)
- 4 Gift Watanabe Todd Franklin gave 1,994 shares (gift)
- 4 Open-market buy Director bought 2,268 shares at an average $13.34 ($30,247)
- 4 Planned sale Matsuda Masaru sold 1,800 shares at $13.78 ($24,807)
- 4 Open-market buy Director bought 5,040 shares at an average $13.66 ($68,821)
- 4 Planned sale Edwards Larry Todd sold 7,451 shares at $14.07 ($104,850)
- 4 Open-market buy Director bought 2,520 shares at $13.62 ($34,317)
- 4 Open-market buy Director bought 8,674 shares at an average $13.76 ($119,352)
- 4 Open-market buy Director bought 6,300 shares at $13.60 ($85,691)
- 4 Planned sale Burnett Patrick sold 3,871 shares at $13.59 ($52,623)
- 4 Grant or award SVP Chief Financial Officer acquired 20,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Matsuda Masaru sold 5,030 shares at $15.20 ($76,453)
- 4 Planned sale Watanabe Todd Franklin sold 11,448 shares at $15.19 ($173,917)
- 4 Planned sale Burnett Patrick sold 2,597 shares at $15.19 ($39,442)
- 4 Planned sale Director sold 10,000 shares at $14.64 ($146,357)
- 4 Planned sale Director sold 10,000 shares at $15.12 ($151,236)
- 4 Planned sale Chief Financial Officer sold 9,600 shares at $15.80 ($151,698)
Page 6 of 23 · 452 filings